Tolerance of the VR Session and Feeling Immersed
anxiety
ADVERSE EVENTS, ADVERSE EVENT
Patients enrolled in the VR group received a short demonstration of VR (5 minutes) to assess their tolerance. During the VR demonstration, most (57/59, 97%) of them watched the entire session, while 2 patients stopped the session: The first patient felt intolerance during the demonstration, and the second patient finally refused VR after completing the demonstration session without an adverse event (Table S2 in For patients who completed the VR program during the biopsy, no adverse events occurred, and only 1 patient experienced a high level of anxiety and switched to MEOPA. Regarding sense of presence, 84% (47/56) of patients felt immersed during the VR session, 73% (41/56) felt elsewhere, and 66% (37/56) felt like they were in a dream (Table S3 in 